The US is expected to back the use of the Pfizer/BioNTech vaccine for people aged 12 to 15 within a week.
Europe's watchdog launched its review on Monday with a decision expected in June.
The US is expected to back the use of the Pfizer/BioNTech vaccine for people aged 12 to 15 within a week.
Europe's watchdog launched its review on Monday with a decision expected in June.
Moderna's COVID-19 vaccine was found to be effective in adolescents aged 12-17 and showed no new or major safety problems in a..
The U.S. Food and Drug Administration is preparing to authorize Pfizer Inc and German partner BioNTech SE's COVID-19 vaccine for..